Ph.D. candidate Anna Moyer reflects on the bittersweet outcome of a clinical trial in children with Down syndrome.
Since pharmaceutical companies began rebranding the pill in the 1990s, use of hormonal birth control for noncontraceptive purposes has exploded. But what has that done to women’s understanding of their own bodies?
Ph.D. candidate Roshan Chikarmane identifies key drivers of rising drug prices and introduces corresponding interventions that are being undertaken by business leaders to shift industry trends toward more affordable health care.
Last weekend, my husband and I visited our local pharmacy to pick up a prescription refill. The pharmacist chatted with us cheerfully as she rang us up at the cash register. Suddenly, her typing stopped. “Wow,” she finally said. “This is expensive.” The small pill bottle sat in her palm as she read off the […]
Imagine a scenario where a patient comes into the clinic with a suspected cancer. The clinician not only confirms that the patient does indeed have cancer, but also identifies a specific gene abnormality that is driving the tumor. Without hesitating, the doctor prescribes a cancer drug that specifically targets the gene mutation responsible for the […]